Products

Therapeutic indications

(Non-reimbursement) Indicated in adults for luteal support as part of an Assisted Reproductive Technology (ART) treatment program in infertile women who are unable to use or tolerate vaginal preparations.

Posology and method of administration

(Non-reimbursement) Once daily injection of 25 mg from day of oocyte retrieval, usually until 12 weeks of confirmed pregnancy.
Choose an appropriate area (femoral quadriceps of the right or left thigh). Swab proposed area, insert a deep injection (needle at an angle from 45° to 90°). The product should be injected slowly to minimize local tissue damage. It is intended for subcutaneous administration.

Package and containing

1 vial X 7

Precautions for storage

Store below 25°C. Do not refrigerate or freeze.
Store in the original package in order to protect from light.

Shelf life

2 years (24 months from the date of manufacture)

Inquiries about the product

T. +82-2-711-0141~2

Inquiries and report on adverse events (AEs)

pv@izenpharma.com

※ For more information, please refer to the insert paper.